Schedule

Three days of Cannabis Innovation - Ten Unique Industry Tracks
Expand All +
  • Day 1 - Professional Training - CME, CPE, CLE, Veterans, Patients, Athletes, Investors

    April 30, 2018

  • Day 2 - Investing, Technology, Industry Standards, Research, New Jersey and International Market Updates

    May 1, 2018

  • Day 3 - The Opioid Epidemic, Data, Technology, Research, and Northeast U.S. Market Updates

    May 2, 2018

  • 12:00 PM - 2:00 PM
    2.0 Substantive CLE credits 2.0 CPE credits The Philadelphia Bar Association is proud to be the CLE provider for the Cannabis Learn Conference and Expo 2018. This 2-hour course offering will take the practitioner through the basics of what a Section 280E audit looks like and both the civil and criminal implications the audit has. IRC 280E is far and away the most important tax provision for the cannabis industry. Currently, licensed “cannabusinesses” have to file federal taxes under IRS tax code 280E because cannabis is still classified as a Schedule 1 drug under the Controlled Substances Act at the federal level. Section 280E denies all deductions of ordinary and necessary business expenses to any business which "consists" of unlawfully "trafficking" in a Schedule I or II controlled substance. As a result, these businesses face exceedingly large tax bills. The cannabis industry is currently subject to an "Information Gathering Project" by the IRS and numerous audits have been commenced. Join your colleagues to learn what IRS Code Section 280E means for “cannabusinesses” at this conference highlighting best practices shaping both the Northeast Corridor of the United States and key international cannabis markets such as Canada and Israel. Note: CPE credit will be offered through Thorburn Walker.
    Business
    Continuing Education
    Professional Training
    Regulatory
    Where
    204 B

  • 12:00 PM - 1:00 PM
    Presented by Debbie Churgai, M.S. and Jahan Marcu, Ph.D. This interactive presentation will cover a variety of topics tailored for patients and their caregivers, that are starting or considering cannabis therapeutics as a part of their healthcare regime. The presenters will cover information on, the endocannabinoid system, the cannabis plant, preparations, and potential side effects, how to choose, use, store, and transport medical cannabis, how to interpret information on labels, what rights and expectations one should have as a medical cannabis consumer, and strategies for talking to doctors, loved ones, employers, and others about legal medical cannabis use. Attendees will be encouraged to ask questions of our presenters who have over 15 years of cumulative experience in research, education, and regulations.
    Medical
    Professional Training
    Research
    Where
    204 C

  • 12:00 PM - 02:00 PM
    Greenhouse Ventures is an early stage venture development organization leading a 2 hour training session for angel investors deploying capital in the cannabis industry. Session Details: Leading angel investors will share tips for evaluating cannabis companies compared to traditional investment opportunities. Learn how to evaluate a company's Unique Value Proposition (UVP), product development timelines, and capitalization strategy. Understand how to align your risk tolerance within a due diligence framework for evaluating qualified investment opportunities.
    Business
    Investing
    Professional Training
    Where
    201

  • 02:00 PM - 04:00 PM
    Athletes for CARE - the 2017 Organization of the Year according to Cannabis Business Awards - will discuss how professional sports leagues around the world are debating how to incorporate cannabis and hemp products into their health, wellness, and pain management practices. Learn how former professional athletes are championing alternative treatment methods like cannabis and bringing the conversation to the forefront of major media.
    Business
    Medical
    Professional Training
    Progressive Topic
    Sports
    Where
    201

  • 02:00 PM - 03:00 PM
    Learn how patients who use medical cannabis can leverage ancillary technology to better understand the data behind how cannabis impacts their health. Session Details: Releaf App demonstrates a mobile technology solution for tracking patient data. Releaf is being used in multiple research studies and has been used by hundreds of patients who have submitted over 100,000 unique data points on cannabis administration, dosing, and the resulting affects of the medicine.
    Medical
    Professional Training
    Research
    Technology
    Where
    204 C

  • 02:00 PM - 02:50 PM
    This course works best for those people who have already achieved a degree of success in their career or, at the very least, those who have intentions of achieving success in the near future. Financial or professional success in your career unfortunately makes you a candidate for attack from a trial attorney and his or her clients. No attorney will file a lawsuit unless he or she thinks that there is money or assets to be obtained through the suit. This course will teach you how to own and control your assets in such a way that only you have access to them. These tools will lock out the trial attorney and, in the process, eliminate the threat of lawsuits. These same tools can be used to reduce your income taxes and, in some cases, help you to eliminate or reduce both estate and capital gains taxes. You have worked hard to create your career; let us teach you how to keep control of that career and all you have worked for.
    Business
    Financial
    Medical
    Professional Training
    Technology
    Where
    204 B

  • 02:00 PM - 02:50 PM
    This session is targeted to a veteran audience, but will also be informative for cannabis industry professionals, researchers, caregivers, and anyone generally interested in serving veterans. The panel is comprised of all veterans, all of whom are cannabis policy, business, advocates, and health professionals. Our goal is to educate, spark conversation, entertain and dispel myths.
    Business
    Medical
    Professional Training
    Research
    Where
    204 A

  • 03:00 PM - 04:00 PM
    From Tinctures, to Edibles, to Topicals, to Transdermal patches. Learn the science, pros, and cons, behind leading administration methods. Session Details: There's more to medical cannabis than smoking and vaping. In fact, leading researchers and technology innovators are pushing the boundaries of cannabis application methods by exploring sophisticated solutions for specific patients with dialed-in needs. Learn about the future of medical cannabis technology commercialization from companies leading the way in topicals, tinctures, edibles, and transdermal patches.
    Medical
    Professional Training
    Technology
    Where
    204 C

  • 10:00 AM - 10:50 AM
    Researchers from Morrisville, the University of Virginia, and the Lehigh University will present individual 18-minute "lightning talks" on industrial hemp research and technology commercialization initiatives taking place within their institutions of higher education.
    Data
    Hemp
    Research
    Where
    204 A

  • 11:00 AM - 11:50 AM
    2017 and 2018 have brought exciting announcements at the intersection of cannabis and professional sports. In 2017, former NBA commissioner, David Stern, said: “I’m now at the point where, personally, I think [cannabis] probably should be removed from the ban list...I think there is universal agreement that marijuana for medical purposes should be completely legal.” During this session, former professional athletes will lead an interactive discussion around the influence cannabis is having within the world of professional sports and mainstream media. Athletes will discuss the implications resulting from CBD being taken off the banned substance list by the World Anti Doping Agency as well as updates on the NFLPA announcing an agreement with the league to look into how cannabis may be used for therapeutic purposes.
    Business
    Medical
    Progressive Topic
    Regulatory
    Sports
    Where
    201 (A, B, C)

  • 01:00 PM - 01:50 PM
    Caretakers and private physicians have been administering cannabis-as-a-medicine with patient groups for decades; however, the data collected from these private studies often remains in an information silo. How are caretakers and private physicians closing the data-feedback loop between the healthcare community, caretakers, and patients? How is dosing controlled? What happens to the data after private research studies are conducted? Session attendees will learn all this and more in the Patient Treatment, Caretakers, Dosing, and Data session.
    Data
    Medical
    Research
    Technology
    Where
    204 A

  • 02:00 PM - 02:50 PM
    The cannabis industry is facing a huge environmental crisis and the leaders of the industry are gathering on stage to discuss solutions for the future. Pesticides, fertilizers, electricity consumption, over-watering, soil runoff, natural resource consumption, and habitat displacement are all a result of a fragmented industry with few unifying best practices. Unfortunately, local communities and consumers are the ones who suffer the most from a lack of regulation around cannabis and hemp production and its affect on the environment. Agricultural and environmental experts will discuss solutions being used by organic farmers and progressive municipalities who are placing the health and wellness of their environment at the top of the priority list.
    Business
    Hemp
    Progressive Topic
    Regulatory
    Technology
    Where
    204 A

  • 02:00 PM - 02:50 PM
    Pennsylvania is positioned to be the Medical Cannabis Research Capital of the United States. Chapter 19 and Chapter 20 of PA Act 16 are helping motivate Pennsylvania universities to join the cannabis industry; however, we need collaboration between universities in order to remove the "information silos" that exist within cannabis research institutions. Learn what Thomas Jefferson University, Temple University, and University of Pennsylvania are studying in the medical cannabis industry.
    Medical
    Research
    University Talk
    Where
    201 (A,B,C)

  • 03:00 PM - 03:50 PM
    Given the lack of standard operating procedures for testing cannabis products, lab testing continues to remain a critical focal point of debate within the industry. How will international markets influence testing standards in the USA? How do different laboratories produce different results when testing the same batch of cannabis? What standards are states are putting in place to ensure quality control and what are lab companies doing to go above and beyond mandated requirements? What are the technology limitations preventing home-testing-kits from being a reliable solution on the market? Learn all this and more at the Lab Testing: Quality Control and Standards session.
    Business
    Data
    Medical
    Regulatory
    Technology
    Where
    204 B

  • 03:20 PM - 04:50 PM
    Demo Day is a 2-hour session where 10 early-stage businesses have the unique opportunity to present their business, on stage, to the cannabis industry's leading investment organizations, media outlets, and 800 lucky attendees. Companies interested in submitting an application to pitch during Demo Day should reach out to info(at)greenhouse(dot)ventures and include "Demo Day Pitch" in the subject line by April 1, 2018 at the latest. CannabisLearn Conference and Expo host, Greenhouse Ventures, will select and notify the top 10 finalists no later than April 21. Selected finalists will be posted in these Session Details after April 21. Presenting businesses will be judged by the Demo Day Investment Committee and winners will be announced on site and awarded prizes.
    Business
    Financial
    Investing
    Technology
    Where
    201 (A, B, C)

  • 01:00 PM - 01:50 PM
    Technology is engrained into every part of the cannabis supply chain, from plant cultivation through product consumption. What ancillary technology firms are leading the industry in sectors such as patient-data collection, strain sequencing, and payment processing? What technological gaps exist in the marketplace that are opening up the doors to new opportunities for emerging technology startups? Join cannabis-tech leaders as they share how they identified a need in the industry by leveraging technology. Learn what to can expect to see in the future as technology innovation becomes a key driver within the cannabis industry.
    Business
    Investing
    Technology
    Where
    204 B

  • 02:00 PM - 02:50 PM
    Researchers from the Colorado State University-Pueblo, University of the Sciences, and the University of New Mexico will present individual 18-minute "lightning talks" on research and technology commercialization initiatives taking place within their institutions of higher education.
    Data
    Medical
    Research
    University Talk
    Where
    Room 204 (B)

  • 02:00 PM - 02:50 PM
    With the cannabis industry facing strict policy guidelines from mainstream marketing and advertising platforms, owners and operators are forced to find alternative and creative solutions to market their venture and build their brand name. How can this be done when many platforms and channels have banned the industry? Leading brands, marketers, and publicists will share insight to the strategies they have chosen and seen success from for their own ventures.
    Business
    Marketing Branding Sales
    Professional Training
    Where
    Room 204 (A)

  • 03:00 PM - 03:50 PM
    According to the National Institute of Drug Abuse, every day 115 Americans die from an opioid overdose. Multiple studies have been released stating that access to medical cannabis significantly drops the number of total opioids prescribed, and leads to a overall lower opioid related overdoses and deaths. In this session, leading legislators, doctors, and patient advocacy groups will discuss the links between medical cannabis and it's impact on curbing the opioid epidemic.
    Medical
    Progressive Topic
    Research
    Where
    Room 201 (A,B,C)